fda compounding semaglutide news today US proposes curbs on mass of Novo, Lilly's weight-loss drugs Some Pharmacies Are Offering Unauthorized

It is commonly used in anti-aging medicine, hormone replacement therapy, and wellness programs to support overall health and vitality

Their ability to regulate blood sugar levels and promote weight loss makes them valuable therapeutic options for individuals with both obesity and diabetes

TRANSCEND-T2D-1 (Lancet, 2026) tested the GIP/GLP-1/glucagon triple agonist in people with T2D managed on diet and exercise alone

[PMC full text] Abdul-Rahman T, et al

Side effects comparison Both medications share similar gastrointestinal side effects, including nausea, vomiting, diarrhoea and constipation

Navigating the Fine Print: How the Finances Work Beneficiaries of the Medicare GLP-1 Bridge program must be enrolled in select Medicare prescription plans, but the program will run separately from standard Medicare